ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 137 filers reported holding ARGENX SE in Q2 2019. The put-call ratio across all filers is 2.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $19,994,000 | -32.3% | 151,779 | -17.5% | 0.64% | -32.6% |
| Q4 2019 | $29,536,000 | -7.8% | 184,000 | -34.5% | 0.94% | -27.9% |
| Q3 2019 | $32,023,000 | -19.5% | 281,000 | 0.0% | 1.31% | -8.6% |
| Q2 2019 | $39,784,000 | -19.1% | 281,000 | -28.6% | 1.43% | -24.2% |
| Q1 2019 | $49,156,000 | +8.4% | 393,750 | -16.6% | 1.88% | +3.9% |
| Q4 2018 | $45,345,000 | -8.9% | 472,000 | -28.1% | 1.82% | +1.8% |
| Q3 2018 | $49,789,000 | +34.4% | 656,500 | +46.9% | 1.78% | +37.0% |
| Q2 2018 | $37,041,000 | +43.9% | 447,029 | +39.7% | 1.30% | +45.9% |
| Q1 2018 | $25,734,000 | +11.4% | 319,920 | -12.6% | 0.89% | -1.9% |
| Q4 2017 | $23,107,000 | +100.8% | 365,961 | -28.1% | 0.91% | +75.5% |
| Q3 2017 | $11,509,000 | +6.6% | 509,022 | 0.0% | 0.52% | -10.1% |
| Q2 2017 | $10,796,000 | – | 509,022 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |